Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA
- 1 December 1994
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 36 (6) , 613-618
- https://doi.org/10.1111/j.1442-200x.1994.tb03255.x
Abstract
An artificial pulmonary surfactant prepared from chloroform-methanol extract of bovine pulmonary surfactant (surfactant TA) has been shown to be effective in both the prevention and the treatment of respiratory distress syndrome in premature babies. Recently, two types of protein-free totally synthetic surfactants, artificial lung expanding compound (ALEC) and Exosurf, have been evaluated in clinical trials of surfactant therapy. Artificial lung expanding compound was used initially as a dry powder, but is now prepared as a crystalline suspension in saline at 4 degrees C. In this study we compared the biophysical properties of three different forms of ALEC (dry powder, crystalline suspension at 4 degrees C and 37 degrees C), Exosurf and surfactant TA (Surfacten) using a modified Wilhelmy surface balance and a pulsating bubble surfactometer. Surface activity of a crystalline suspension of ALEC in cold saline was no better than the dry powder of ALEC. Surfactant activity of ALEC was improved by addition of hydrophobic surfactant protein B and C (SP-B, SP-C) which are important constituents of surfactant TA. Surface properties of ALEC in any form and Exosurf were not superior to those of surfactant TA. These results suggest that a surfactant which contains SP-B and SP-C does not necessarily have to be dry or crystalline for an effective exogenous surfactant.Keywords
This publication has 15 references indexed in Scilit:
- Surfactant Replacement Therapy in Premature Babies with Respiratory Distress Syndrome: Factors Affecting the Response to Surfactant and Comparison of Outcome from 1982–86 and 1987–91Pediatrics International, 1992
- Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactantThe Journal of Pediatrics, 1990
- Structure-function relationships of bovine pulmonary surfactant proteins: SP-B and SP-CBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestationEarly Human Development, 1988
- Lung Function in Prematurely Delivered Rabbits Treated with a Synthetic SurfactantAmerican Review of Respiratory Disease, 1987
- DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASEThe Lancet, 1987
- Proteolipid in bovine lung surfactant: Its role in surfactant functionBiochemical and Biophysical Research Communications, 1986
- Introductory remarks about artificial lung expanding compounds (ALEC)Colloids and Surfaces, 1984
- DRY ARTIFICIAL LUNG SURFACTANT AND ITS EFFECT ON VERY PREMATURE BABIESPublished by Elsevier ,1981
- ARTIFICIAL SURFACTANT THERAPY IN HYALINE-MEMBRANE DISEASEThe Lancet, 1980